Nice University Hospital
Nice, 06000, France
NCT Number: NCT05866822
This study aims to compare the effect of a program of Adapted Physical Activity (APA) versus the same program combined with a physical activity education program (PAE). Patients suffering from neurocognitive disorders (mild or early major) will be randomized into one of the two conditions. 3 complete evaluations will be done (inclusion M0, after 3 month of intervention M3, 3 months after the end of the intervention M6). The team except that APA+PEA will be more effectiv than the APA solely, on the following criteria : level of physical activity, cogntive function and quality of life.
Looking for future studies?
Notify Me70 year and older
All sexes
Interventional
Not applicable
Nice, 06000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
24 APA sessions
8 individuals sessions of PAE
Time frame: at inclusion
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
Time frame: at 3 months after inclusion
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
Time frame: at 6 months after inclusion
evolution of physical activity level will be assessed by actimetry on a 7 days period mesured by IPAQ score
Time frame: at inclusion
global cognition will be assessed by a MMSE test (Mini Mental State Examination) mesured by a score
Time frame: at 3 months after inclusion
global cognition will be assessed by a MMSE test (Mini Mental State Examination) mesured by a score
Time frame: at 6 months after inclusion
global cognition will be assessed by a MMSE test (Mini Mental State Examination) mesured by a score
Time frame: at inclusion
executiv functions will be assessed by FAB (frontal assessment battery)
Time frame: at 3 months after inclusion
executiv functions will be assessed by FAB (frontal assessment battery)
Time frame: at 6 months after inclusion
executiv functions will be assessed by FAB (frontal assessment battery)
Time frame: at inclusion
executiv functions will be assessed by FAB (frontal assessment battery) giving a score
Time frame: at 3 months after inclusion
executiv functions will be assessed by FAB (frontal assessment battery) giving a score
Time frame: at 6 months after inclusion
executiv functions will be assessed by FAB (frontal assessment battery) giving a score
Time frame: at inclusion
executiv functions will be assessed by TMT (frontal assessment battery) - giving a score
Time frame: at 3 months after inclusion
executiv functions will be assessed by TMT (frontal assessment battery) - giving a score
Time frame: at 6 months after inclusion
executiv functions will be assessed by TMT (frontal assessment battery) - giving a score
Time frame: at inclusion
Cardiovascular performance will be evaluated through a effort test that will be performed on a stationary bicycle ergometer connected to a portable gas exchange analysis system in ml/kg/min
Time frame: at 3 months after inclusion
Cardiovascular performance will be evaluated through a effort test that will be performed on a stationary bicycle ergometer connected to a portable gas exchange analysis system in ml/kg/min
Time frame: at 6 months after inclusion
Cardiovascular performance will be evaluated through a effort test that will be performed on a stationary bicycle ergometer connected to a portable gas exchange analysis system in ml/kg/min
Time frame: at inclusion
physical condition will be asessed by lower extremity power (isokinetic ergometer) with a score
Time frame: at 3 months after inclusion
physical condition will be asessed by lower extremity power (isokinetic ergometer) with a score
Time frame: at 6 months after inclusion
physical condition will be asessed by lower extremity power (isokinetic ergometer) with a score
Time frame: at inclusion
physical condition will be asessed by grip strength (hand grip) with a score
Time frame: at 3 months after inclusion
physical condition will be asessed by grip strength (hand grip) with a score
Time frame: at 6 months after inclusion
physical condition will be asessed by grip strength (hand grip) with a score
Time frame: at inclusion
quality of life will be assessed by SF 12 a short version of the MEDICAL OUTCOME STUDY SHORT FORME GENERAL HEALTH SURVEY (score)
Time frame: at 3 months after inclusion
quality of life will be assessed by SF 12 a short version of the MEDICAL OUTCOME STUDY SHORT FORME GENERAL HEALTH SURVEY (score)
Time frame: at 6 months after inclusion
quality of life will be assessed by SF 12 a short version of the MEDICAL OUTCOME STUDY SHORT FORME GENERAL HEALTH SURVEY (score)
Time frame: at inclusion
anxiety and depression will be assessed by the HADS " Hospital Anxiety and Depression Scale " and giving a score
Time frame: at 3 months after inclusion
anxiety and depression will be assessed by the HADS " Hospital Anxiety and Depression Scale " and giving a score
Time frame: at 6 months after inclusion
anxiety and depression will be assessed by the HADS " Hospital Anxiety and Depression Scale " and giving a score
Time frame: at inclusion
apathy will be assessed by the apathy inventory questionnary and givig a score
Time frame: at 3 months after inclusion
apathy will be assessed by the apathy inventory questionnary and givig a score
Time frame: at 6 months after inclusion
apathy will be assessed by the apathy inventory questionnary and givig a score
Centre Hospitalier Universitaire de Nice
Other
Adapted Physical Activity Education in Patients With Neurocognitive Disorder: Single-blind, Single-center Randomized Controlled Trial
Acronym: EduAPA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05318976
Alzheimer Disease, Brain Diseases
Darlinghurst, New South Wales, Australia
View Trial DetailsNCT06463093
Mental Disorders, Neurocognitive Disorders
Vandœuvre-lès-Nancy, France
View Trial DetailsNCT07041008
Alzheimer Disease, Anxiety Disorders
Leiria, Leria, Portugal
View Trial DetailsNCT04610515
COVID-19, Cardiovascular Diseases
Los Angeles, California, United States
View Trial Details